The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,142.00
Bid: 2,140.00
Ask: 2,144.00
Change: 66.00 (3.18%)
Spread: 4.00 (0.187%)
Open: 2,084.00
High: 2,148.00
Low: 2,084.00
Prev. Close: 2,076.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£250 Million US Private Placement

22 Nov 2018 07:00

RNS Number : 1314I
Derwent London PLC
22 November 2018
 

Derwent London plc ("Derwent London" / "the Group")

DERWENT LONDON £250 MILLION US PRIVATE PLACEMENT

 

Derwent London announces that it has signed an agreement with eight institutional investors for a private placement of £250 million new senior unsecured notes. The issue consists of four tranches with maturities ranging between 7 and 15 years. The weighted average coupon of the fixed rate notes equates to 2.89% with a weighted average maturity of 10.8 years.

 

The four tranches, to be drawn on 31 January 2019, are: £55 million at 2.68% due 2026, £93 million at 2.87% due 2029, £50 million at 2.97% due 2031 and £52 million at 3.09% due 2034.

 

The issue was priced on 31 October 2018 and the note purchase agreement signed on 21 November 2018. The funds will be used for general corporate purposes and to refinance existing Group indebtedness.

 

Barclays, HSBC, NatWest Markets and Wells Fargo acted as joint placement agents. 

 

Damian Wisniewski, Finance Director of Derwent London, commented:

"We are very pleased with the support that this issue received both from existing and new investors. With our recent credit rating upgrade, a September 2018 loan-to-value ratio of 16.3% and strong interest cover, the Group is well placed to fund its pipeline of value-enhancing projects and to continue growing earnings. When drawn in January 2019, the issue will increase our available facilities and extend our weighted average debt maturity."

 

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 7659 3000

 

 

Damian Wisniewski, Finance Director

Jay Joshi, Treasurer

Quentin Freeman, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

Nina Coad

Emily Trapnell

 

 

 

 

 

 

Notes to editors

 

Derwent London plc

 

Derwent London plc owns 87 buildings in a commercial real estate portfolio predominantly in central London valued at £5.0 billion (including joint ventures) as at 30 June 2018, making it the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

 

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

 

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

Landmark schemes in our 5.5 million sq ft portfolio include White Collar Factory EC1, Angel Building EC1, The Buckley Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

 

In 2018 to date the Group has won Property Week Property Company of the Year and EG Offices Company of the Year, whilst White Collar Factory scooped RIBA National and London awards, RICS National and London awards, two BCO awards for Commercial Workplace and Innovation, an EG Creative Places award and an NLA Wellbeing award. 25 Savile Row also won RIBA National and London awards and SKA Gold for the fit-out. In 2017 the Group collected the Property Week Developer of the Year award and EG Offices Company of the Year and won further awards from RIBA, Civic Trust and BCO. In 2013 Derwent London launched a voluntary Community Fund and has to date supported 70 community projects in Fitzrovia and the Tech Belt.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

 

 

Forward-looking statements

 

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

 

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRUAUBRWUAAUAA
Date   Source Headline
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company
28th Feb 20224:45 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSResults for the Year Ended 31 December 2021
31st Jan 20224:45 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSSALE OF NEW RIVER YARD EC1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.